Natus Medical entered into a credit agreement with JPMorgan Chase Bank and Citibank.

The agreement has an accordion feature allowing the company to increase the revolving credit facility available to it with term loans not to exceed $75 million in aggregate.

Effective September 15, 2017, the company exercised its rights under that accordion feature to increase the revolving credit facility by $75 million, increasing the aggregate revolving credit facility from $150 million to $225 million.

In addition, Wells Fargo Bank became a lender under the terms of the credit agreement.

Natus Medical is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care.